PTP1B-deficient mice are hypersensitive to insulin and resistant to obesity induced by a calorie-rich diet.5 For this reason, PTP1B has received attention over the last few years as a novel therapeutic target for the treatment of diabetes and obesity, and as such there are numerous inhibitors against PTP1B at various stages of development.6 This evidence concerns the gene PTPN1 and diabetes mellitus.